Matthew Richard Moore's Net Worth
$1.62 Million
Who is Matthew Richard Moore?
Matthew Richard Moore has an estimated net worth of $1.62 Million. This is based on reported shares across multiple companies, which include Arcutis Biotherapeutics, Inc., and Ventyx Biosciences, Inc..
SEC CIK
Matthew Richard Moore's CIK is 0001840191
Past Insider Trading and Trends
2024 was Matthew Richard Moore's most active year for acquiring shares with 9 total transactions. Matthew Richard Moore's most active month to acquire stocks was the month of January. 2024 was Matthew Richard Moore's most active year for disposing of shares, totalling 7 transactions. Matthew Richard Moore's most active month to dispose stocks was the month of January. 2024 saw Matthew Richard Moore paying a total of $0.00 for 573,064 shares, this is the most they've acquired in one year. In 2024 Matthew Richard Moore cashed out on 255,449 shares for a total of $79,469.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $10.38
SVP and Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.35% | -515.00 |
$8.74 | -$40,901.64 | 145.5K |
Scheduled
|
May 1 - May 2
| ||
Form 4
| -2.32% | -3.47K |
$11.12 | -$38,568.32 | 146.02K |
Scheduled
|
Mar 4
| ||
Form 4
| +173.84% | 94.9K |
—
|
—
| 149.49K |
Feb 13
| |||
Form 4
| +105.30% | 28K |
—
|
—
| 54.59K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
| +99.92% | 13.29K |
$15.83 | -$25,481.25 | 26.59K |
Scheduled
|
Mar 2
| ||
Form 4
|
∞
| 13.3K |
—
|
—
| 13.3K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||